Whole Virion, Inactivated Corona Virus Vaccine [Covaxin]

• On 19 April 2021, the Food and Drug Administration (FDA) issued conditional authorization granting IP BIOTECH, INC. the emergency use approval of Whole Virion, Inactivated Corona Virus Vaccine [Covaxin].
  
  

                  Product Information
                  English

• Information on the safety of Whole Virion, Inactivated Corona Virus Vaccine [Covaxin] is discussed in their comprehensive Risk Management Plan.
• For more information on reporting side effects, click here.